Abstract
A potential anticancer heterodinuclear ruthenium(II)-platinum(II) complex, [ruthenium(II)(4,4′-dimethyl-2,2′-bipyridine)2(5-(l-cysteine-methyl ester)-1,10-phenanthroline)-trans-chlorodiammineplatinum(II)] chloride, [Ru(Me2bipy)2(5-(l-cysteine-Me)-phen)-trans-Pt(NH3)2Cl]Cl3, was synthesised. l-Cysteine methyl ester was used to link the two metal centres, as more conventional straight chain diaminoalkanes and 2-mercaptoethylamine failed to couple to the phenanthroline ligand. From the precursor mononuclear ruthenium(II) complexes, which were separated into their -- and Λ-isomers by column chromatography, the dinuclear complex was synthesised and characterised by 1H and 13C NMR, UV-Vis, circular dichroism, fluorescence and electrospray ionisation mass spectrometry.
Original language | English |
---|---|
Pages (from-to) | 318-328 |
Number of pages | 10 |
Journal | Polyhedron |
Volume | 26 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2007 |
Keywords
- ruthenium(II)
- platinum(II)
- heterodinuclear
- L-Cysteine methyl ester
- phenanthroline
- anticancer
- pharmacological sciences